Enrollment Target for Adult Sickle Cell Disease Patients Achieved in BEACON Trial ofBEAM-101; Dosing of 30 Patients and ...

Beam Therapeutics (BEAM) delivered earnings and revenue surprises of 0.91% and 44.12%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Beam expects that its cash, cash equivalents and marketable securities as of December 31, 2024, will enable the company to fund its anticipated ...

Reports Q4 revenue $30.1M, consensus $16.47M. “We are incredibly proud of the significant progress and momentum across our hematology and ...

Floating in the Rio Negro river in the Brazilian Amazon, Luiz Felipe, who has Down Syndrome, beams as he hugs a pink dolphin ...

A mother from Cannock who watched her identical twin boys go through tough cancer treatment - just weeks apart - has welcomed ...

The £1m grant will help fund the University of Birmingham research into ‘the next generation’ of radiotherapy treatments that ...

Proton arc therapy offers a superior dose distribution compared with existing state-of-the-art proton delivery techniques ...

Vogue catches up with Corona at her new residence, where days are spent tending to the vegetable garden, enjoying a cup of ...

David said: “I’ve been very healthy all my life, so I consider myself lucky to have got to my age without anything serious.

Stork Club, a pioneering reproductive healthcare benefits provider, today unveiled the industry's first fully integrated ...